Gabriela Stefania Reyes Gutierrez

Ms. Gabriela Stefania Reyes Gutierrez

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2022 in Gaceta Médica de México
Verified
Journal Article
Closed access
LGLaura Gómez-Virgilio
Laura Gómez-Virgilio
GGGabriela Stefania Reyes Gutierrez
Gabriela Stefania Reyes Gutierrez
MSMaría del C. Silva-Lucero
María del C. Silva-Lucero
GLGustavo López-Toledo
Gustavo López-Toledo
MCMaría del C. Cárdenas-Aguayo
María del C. Cárdenas-Aguayo

Verified
Journal Article
Open access
PDF file
NGNidia Jannette Carrillo González
Nidia Jannette Carrillo González
GGGabriela Stefania Reyes Gutierrez
Gabriela Stefania Reyes Gutierrez
TCTania Campos-Ordonez
Tania Campos-Ordonez
RCRubén Darío Castro-Torres
Rubén Darío Castro-Torres
CBCarlos Beas-Zarate
Carlos Beas-Zarate
GCGraciela Gudiño Cabrera
Graciela Gudiño Cabrera
Olfactory ensheathing cells (OECs) and mesenchymal stem cells (MSCs) differentiated towards Schwann-like have plasticity properties. These cells express the Glial fibrillary acidic protein (GFAP), a type of cytoskeletal protein that significantly regulates many cellular functions, including those that promote cellular plasticity needed for regeneration. However, the expression of GFAP isoforms (α, β, and δ) in these cells has not been characterized. We evaluated GFAP isoforms (α, β, and δ) expression by Polymerase Chain Reaction (PCR) assay in three conditions: (1) OECs, (2) cells exposed to OECs-conditioned medium and differentiated to Schwann-like cells (dBM-MSCs), and (3) MSC cell culture from rat bone marrow undifferentiated (uBM-MSCs). First, the characterization phenotyping was verified by morphology and immunocytochemistry, using p75, CD90, and GFAP antibodies. Then, we found the expression of GFAP isoforms (α, β, and δ) in the three conditions; the expression of the GFAPα (10.95%AUC) and GFAPβ (9.17%AUC) isoforms was predominantly in OECs, followed by dBM-MSCs (α: 3.99%AUC, β: 5.66%AUC) and uBM-MSCs (α: 2.47%AUC, β: 2.97%AUC). GFAPδ isoform has a similar expression in the three groups (OEC: 9.21%AUC, dBM-MSCs: 11.10%AUC, uBM-MSCs: 9.21%AUC). These findings suggest that expression of different GFAPδ and GFAPβ isoforms may regulate cellular plasticity properties, potentially contributing to tissue remodeling processes by OECs, dBM-MSCs, and uBM-MSCs.